Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Submitted on July 30, 2004
Accepted on October 22, 2004
Lysosomal Glycosphingolipid Recognition by NKT cells
Dapeng Zhou 1*, Jochen Mattner 1, Carlos Cantu III 2, Nicolas Schrantz 2, Ning Yin 3, Ying Gao 3, Yuval Sagiv 1, Kelly Hudspeth 1, Yunping Wu 4, Tadashi Yamashita 4, Susann Teneberg 5, Dacheng Wang 6, Richard Proia 4, Steven B. Levery 7, Paul B. Savage 3, Luc Teyton 2, Albert Bendelac 1*
1 University of Chicago, Department of Pathology, Chicago, IL 60637, USA. 2 The Scripps Research Institute, Department of Immunology, La Jolla, CA 92037, USA. 3 Brigham Young University, Department of Chemistry and Biochemistry, Provo, UT 84602-5700, USA. 4 Genetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA. 5 Institute of Medical Biochemistry, Göteborg University, SE 405 30 Göteborg, Sweden. 6 Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, P. R. China. 7 Department of Chemistry, University of New Hampshire, Durham, NH 03824-3598, USA.
* To whom correspondence should be addressed.
Dapeng Zhou , E-mail: dzhou{at}midway.uchicago.edu Albert Bendelac , E-mail: abendela{at}bsd.uchicago.edu
NKT cells represent a distinct lineage of T cells that coexpressa conserved T cell receptor (TCR) and natural killer (NK) receptors.Although the TCR of NKT cells is characteristically autoreactiveto CD1d, a lipid-presenting molecule, endogenous ligands forthese cells have not been identified. We show that a lysosomalglycosphingolipid of previously unknown function, isoglobotrihexosylceramide(iGb3), is recognized both by mouse and human NKT cells. Impairedgeneration of lysosomal iGb3 in mice lacking -hexosaminidaseb results in severe NKT cell deficiency, suggesting that thislipid also mediates development of NKT cells in the mouse. Wesuggest that expression of iGb3 in peripheral tissues may beinvolved in controlling NKT cell responses to infections andmalignancy and in autoimmunity.
The editors suggest the following Related Resources on Science sites:
In Science Magazine
PERSPECTIVES
Dale I. Godfrey, Daniel G. Pellicci, and Mark J. Smyth (3 December 2004) Science306 (5702), 1687.
[DOI: 10.1126/science.1106932] |Summary »|Full Text »|PDF »
The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy.
M. Taniguchi, T. Tashiro, N. Dashtsoodol, N. Hongo, and H. Watarai (2009)
Int. Immunol.
|Abstract »|Full Text »|PDF »
EBV-Induced Human CD8+ NKT Cells Suppress Tumorigenesis by EBV-Associated Malignancies.
H. Yuling, X. Ruijing, L. Li, J. Xiang, Z. Rui, W. Yujuan, Z. Lijun, D. Chunxian, T. Xinti, X. Wei, et al. (2009)
Cancer Res.
69, 7935-7944
|Abstract »|Full Text »|PDF »
Human NKT cells promote monocyte differentiation into suppressive myeloid antigen-presenting cells.
S. Hegde, E. Jankowska-Gan, D. A. Roenneburg, J. Torrealba, W. J. Burlingham, and J. E. Gumperz (2009)
J. Leukoc. Biol.
86, 757-768
|Abstract »|Full Text »|PDF »
Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis?.
M Podbielska and E. Hogan (2009)
Multiple Sclerosis
15, 1011-1029
|Abstract »|PDF »
NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-{gamma} and CXCR3 chemokines.
K. L. Wallace, M. A. Marshall, S. I. Ramos, J. A. Lannigan, J. J. Field, R. M. Strieter, and J. Linden (2009)
Blood
114, 667-676
|Abstract »|Full Text »|PDF »
Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis.
M. S. Bharhani, B. Chiu, K.-S. Na, and R. D. Inman (2009)
Int. Immunol.
21, 859-870
|Abstract »|Full Text »|PDF »
CD1c bypasses lysosomes to present a lipopeptide antigen with 12 amino acids.
I. Van Rhijn, D. C. Young, A. De Jong, J. Vazquez, T.-Y. Cheng, R. Talekar, D. C. Barral, L. Leon, M. B. Brenner, J. T. Katz, et al. (2009)
J. Exp. Med.
206, 1409-1422
|Abstract »|Full Text »|PDF »
Intrathymic proliferation wave essential for V{alpha}14+ natural killer T cell development depends on c-Myc.
M. Dose, B. P. Sleckman, J. Han, A. L. Bredemeyer, A. Bendelac, and F. Gounari (2009)
PNAS
106, 8641-8646
|Abstract »|Full Text »|PDF »
NKT Cell Subsets Mediate Differential Proatherogenic Effects in ApoE-/- Mice.
K. To, A. Agrotis, G. Besra, A. Bobik, and B.-H. Toh (2009)
Arterioscler Thromb Vasc Biol
29, 671-677
|Abstract »|Full Text »|PDF »
PD-1/PD-L Blockade Prevents Anergy Induction and Enhances the Anti-Tumor Activities of Glycolipid-Activated Invariant NKT Cells.
V. V. Parekh, S. Lalani, S. Kim, R. Halder, M. Azuma, H. Yagita, V. Kumar, L. Wu, and L. Van Kaer (2009)
J. Immunol.
182, 2816-2826
|Abstract »|Full Text »|PDF »
Importance of NKT Cells in Resistance to Herpes Simplex Virus, Fate of Virus-Infected Neurons, and Level of Latency in Mice.
B. Grubor-Bauk, J. L. Arthur, and G. Mayrhofer (2008)
J. Virol.
82, 11073-11083
|Abstract »|Full Text »|PDF »
Enhanced Early Expansion and Maturation of Semi-Invariant NK T Cells Inhibited Autoimmune Pathogenesis in Congenic Nonobese Diabetic Mice.
A. Ueno, J. Wang, L. Cheng, J. S. Im, Y. Shi, S. A. Porcelli, and Y. Yang (2008)
J. Immunol.
181, 6789-6796
|Abstract »|Full Text »|PDF »
Natural killer T-cell autoreactivity leads to a specialized activation state.
X. Wang, X. Chen, L. Rodenkirch, W. Simonson, S. Wernimont, R. M. Ndonye, N. Veerapen, D. Gibson, A. R. Howell, G. S. Besra, et al. (2008)
Blood
112, 4128-4138
|Abstract »|Full Text »|PDF »
{beta}-Glycosphingolipids-mediated lipid raft alteration is associated with redistribution of NKT cells and increased intrahepatic CD8+ T lymphocyte trapping.
G. Lalazar, A. Ben Ya'acov, N. Eliakim-Raz, D. M. Livovsky, O. Pappo, S. Preston, L. Zolotarov, and Y. Ilan (2008)
J. Lipid Res.
49, 1884-1893
|Abstract »|Full Text »|PDF »
Congenic Analysis of the NKT Cell Control Gene Nkt2 Implicates the Peroxisomal Protein Pxmp4.
J. M. Fletcher, M. A. Jordan, S. L. Snelgrove, R. M. Slattery, F. D. Dufour, K. Kyparissoudis, G. S. Besra, D. I. Godfrey, and A. G. Baxter (2008)
J. Immunol.
181, 3400-3412
|Abstract »|Full Text »|PDF »
Invariant NKT Cells Regulate Experimental Autoimmune Encephalomyelitis and Infiltrate the Central Nervous System in a CD1d-Independent Manner.
L. T. Mars, A.-S. Gautron, J. Novak, L. Beaudoin, J. Diana, R. S. Liblau, and A. Lehuen (2008)
J. Immunol.
181, 2321-2329
|Abstract »|Full Text »|PDF »
IFN-{gamma}-Producing Human Invariant NKT Cells Promote Tumor-Associated Antigen-Specific Cytotoxic T Cell Responses.
M. Moreno, J. W. Molling, S. von Mensdorff-Pouilly, R. H. M. Verheijen, E. Hooijberg, D. Kramer, A. W. Reurs, A. J. M. van den Eertwegh, B. M. E. von Blomberg, R. J. Scheper, et al. (2008)
J. Immunol.
181, 2446-2454
|Abstract »|Full Text »|PDF »
Influence of a Non-NK Complex Region of Chromosome 6 on CD4+ Invariant NK T Cell Homeostasis.
D. Vallois, M.-C. Gagnerault, P. Avner, U. C. Rogner, C. Boitard, K. Benlagha, A. Herbelin, and F. Lepault (2008)
J. Immunol.
181, 1753-1759
|Abstract »|Full Text »|PDF »
Activation-induced NKT cell hyporesponsiveness protects from {alpha}-galactosylceramide hepatitis and is independent of active transregulatory factors.
IL-2 triggers specific signaling pathways in human NKT cells leading to the production of pro- and anti-inflammatory cytokines.
S. Bessoles, F. Fouret, S. Dudal, G. S. Besra, F. Sanchez, and V. Lafont (2008)
J. Leukoc. Biol.
84, 224-233
|Abstract »|Full Text »|PDF »
IL-15 Expands Unconventional CD8{alpha}{alpha}NK1.1+ T Cells but Not V{alpha}14J{alpha}18+ NKT Cells.
M. Terabe, Y. Tagaya, Q. Zhu, L. Granger, M. Roederer, T. A. Waldmann, and J. A. Berzofsky (2008)
J. Immunol.
180, 7276-7286
|Abstract »|Full Text »|PDF »
MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells.
S. Huang, S. Gilfillan, S. Kim, B. Thompson, X. Wang, A. J. Sant, D. H. Fremont, O. Lantz, and T. H. Hansen (2008)
J. Exp. Med.
205, 1201-1211
|Abstract »|Full Text »|PDF »
Dendritic Cell Differentiation State and Their Interaction with NKT Cells Determine Th1/Th2 Differentiation in the Murine Model of Leishmania major Infection.
C. Wiethe, A. Debus, M. Mohrs, A. Steinkasserer, M. Lutz, and A. Gessner (2008)
J. Immunol.
180, 4371-4381
|Abstract »|Full Text »|PDF »
Aberrant Genetic Control of Invariant TCR-Bearing NKT Cell Function in New Zealand Mouse Strains: Possible Involvement in Systemic Lupus Erythematosus Pathogenesis.
K. Tsukamoto, M. Ohtsuji, W. Shiroiwa, Q. Lin, K. Nakamura, H. Tsurui, Y. Jiang, K. Sudo, H. Nishimura, T. Shirai, et al. (2008)
J. Immunol.
180, 4530-4539
|Abstract »|Full Text »|PDF »
The vitamin D receptor is required for iNKT cell development.
Involvement of Secretory and Endosomal Compartments in Presentation of an Exogenous Self-Glycolipid to Type II NKT Cells.
K. C. Roy, I. Maricic, A. Khurana, T. R. F. Smith, R. C. Halder, and V. Kumar (2008)
J. Immunol.
180, 2942-2950
|Abstract »|Full Text »|PDF »
Cutting Edge: Activation by Innate Cytokines or Microbial Antigens Can Cause Arrest of Natural Killer T Cell Patrolling of Liver Sinusoids.
P. Velazquez, T. O. Cameron, Y. Kinjo, N. Nagarajan, M. Kronenberg, and M. L. Dustin (2008)
J. Immunol.
180, 2024-2028
|Abstract »|Full Text »|PDF »
A Critical Role of Costimulation during Intrathymic Development of Invariant NK T Cells.
Y. Chung, R. Nurieva, E. Esashi, Y.-H. Wang, D. Zhou, L. Gapin, and C. Dong (2008)
J. Immunol.
180, 2276-2283
|Abstract »|Full Text »|PDF »
Sensitive quantitation of isoglobotriaosylceramide in the presence of isobaric components using electrospray ionization-ion trap mass spectrometry.
Y. Li, D. Zhou, C. Xia, P. G. Wang, and S. B. Levery (2008)
Glycobiology
18, 166-176
|Abstract »|Full Text »|PDF »
Sensitive detection of isoglobo and globo series tetraglycosylceramides in human thymus by ion trap mass spectrometry.
Y. Li, S. Teneberg, P. Thapa, A. Bendelac, S. B. Levery, and D. Zhou (2008)
Glycobiology
18, 158-165
|Abstract »|Full Text »|PDF »
Role of NKT cells in the digestive system. IV. The role of canonical natural killer T cells in mucosal immunity and inflammation.
G. Wingender and M. Kronenberg (2008)
Am J Physiol Gastrointest Liver Physiol
294, G1-G8
|Abstract »|Full Text »|PDF »
S1P1 receptor expression regulates emergence of NKT cells in peripheral tissues.
M. L. Allende, D. Zhou, D. N. Kalkofen, S. Benhamed, G. Tuymetova, C. Borowski, A. Bendelac, and R. L. Proia (2008)
FASEB J
22, 307-315
|Abstract »|Full Text »|PDF »
Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation.
M. Salio, A. O. Speak, D. Shepherd, P. Polzella, P. A. Illarionov, N. Veerapen, G. S. Besra, F. M. Platt, and V. Cerundolo (2007)
PNAS
104, 20490-20495
|Abstract »|Full Text »|PDF »
Critical Role for CXC Chemokine Ligand 16 (SR-PSOX) in Th1 Response Mediated by NKT Cells.
T. Shimaoka, K.-i. Seino, N. Kume, M. Minami, C. Nishime, M. Suematsu, T. Kita, M. Taniguchi, K. Matsushima, and S. Yonehara (2007)
J. Immunol.
179, 8172-8179
|Abstract »|Full Text »|PDF »
Modulation of CD1d-restricted NKT cell responses by CD4.
X. Chen, X. Wang, G. S. Besra, and J. E. Gumperz (2007)
J. Leukoc. Biol.
82, 1455-1465
|Abstract »|Full Text »|PDF »
Role of NKT Cells in the Digestive System. III. Role of NKT cells in intestinal immunity.
S. Zeissig, A. Kaser, S. K. Dougan, E. E. S. Nieuwenhuis, and R. S. Blumberg (2007)
Am J Physiol Gastrointest Liver Physiol
293, G1101-G1105
|Abstract »|Full Text »|PDF »
Invariant NKT Cells Biased for IL-5 Production Act as Crucial Regulators of Inflammation.
K. Sakuishi, S. Oki, M. Araki, S. A. Porcelli, S. Miyake, and T. Yamamura (2007)
J. Immunol.
179, 3452-3462
|Abstract »|Full Text »|PDF »
A Y Chromosome-Linked Factor Impairs NK T Development.
J. D. Wesley, M. S. Tessmer, C. Paget, F. Trottein, and L. Brossay (2007)
J. Immunol.
179, 3480-3487
|Abstract »|Full Text »|PDF »
A Single Early Activation of Invariant NK T Cells Confers Long-Term Protection against Collagen-Induced Arthritis in a Ligand-Specific Manner.
K. Coppieters, K. Van Beneden, P. Jacques, P. Dewint, A. Vervloet, B. Vander Cruyssen, S. Van Calenbergh, G. Chen, R. W. Franck, G. Verbruggen, et al. (2007)
J. Immunol.
179, 2300-2309
|Abstract »|Full Text »|PDF »
CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells.
A. Thedrez, C. de Lalla, S. Allain, L. Zaccagnino, S. Sidobre, C. Garavaglia, G. Borsellino, P. Dellabona, M. Bonneville, E. Scotet, et al. (2007)
Blood
110, 251-258
|Abstract »|Full Text »|PDF »
Distinct Endosomal Trafficking Requirements for Presentation of Autoantigens and Exogenous Lipids by Human CD1d Molecules.
X. Chen, X. Wang, J. M. Keaton, F. Reddington, P. A. Illarionov, G. S. Besra, and J. E. Gumperz (2007)
J. Immunol.
178, 6181-6190
|Abstract »|Full Text »|PDF »
Identification of an IL-17-producing NK1.1neg iNKT cell population involved in airway neutrophilia.
M.-L. Michel, A. C. Keller, C. Paget, M. Fujio, F. Trottein, P. B. Savage, C.-H. Wong, E. Schneider, M. Dy, and M. C. Leite-de-Moraes (2007)
J. Exp. Med.
204, 995-1001
|Abstract »|Full Text »|PDF »
Primary Infection of C57BL/6 Mice with Plasmodium yoelii Induces a Heterogeneous Response of NKT Cells.
V. Soulard, J. Roland, C. Sellier, A. C. Gruner, M. Leite-de-Moraes, J.-F. Franetich, L. Renia, P.-A. Cazenave, and S. Pied (2007)
Infect. Immun.
75, 2511-2522
|Abstract »|Full Text »|PDF »
Invariant and Noninvariant Natural Killer T Cells Exert Opposite Regulatory Functions on the Immune Response during Murine Schistosomiasis.
T. Mallevaey, J. Fontaine, L. Breuilh, C. Paget, A. Castro-Keller, C. Vendeville, M. Capron, M. Leite-de-Moraes, F. Trottein, and C. Faveeuw (2007)
Infect. Immun.
75, 2171-2180
|Abstract »|Full Text »|PDF »
Long-term evolution of the CAZY glycosyltransferase 6 (ABO) gene family from fishes to mammals--a birth-and-death evolution model.
A.-L. Turcot-Dubois, B. Le Moullac-Vaidye, S. Despiau, F. Roubinet, N. Bovin, J. Le Pendu, and A. Blancher (2007)
Glycobiology
17, 516-528
|Abstract »|Full Text »|PDF »
NKT cells direct monocytes into a DC differentiation pathway.
S. Hegde, X. Chen, J. M. Keaton, F. Reddington, G. S. Besra, and J. E. Gumperz (2007)
J. Leukoc. Biol.
81, 1224-1235
|Abstract »|Full Text »|PDF »
The Pro-Th1 Cytokine IL-12 Enhances IL-4 Production by Invariant NKT Cells: Relevance for T Cell-Mediated Hepatitis.
R. Zhu, S. Diem, L. M. Araujo, A. Aumeunier, J. Denizeau, E. Philadelphe, D. Damotte, M. Samson, P. Gourdy, M. Dy, et al. (2007)
J. Immunol.
178, 5435-5442
|Abstract »|Full Text »|PDF »
The Niemann-Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells.
N. Schrantz, Y. Sagiv, Y. Liu, P. B. Savage, A. Bendelac, and L. Teyton (2007)
J. Exp. Med.
204, 841-852
|Abstract »|Full Text »|PDF »
A distal effect of microsomal triglyceride transfer protein deficiency on the lysosomal recycling of CD1d.
Y. Sagiv, L. Bai, D. G. Wei, R. Agami, P. B. Savage, L. Teyton, and A. Bendelac (2007)
J. Exp. Med.
204, 921-928
|Abstract »|Full Text »|PDF »
Interdependency of MHC Class II/Self-Peptide and CD1d/Self-Glycolipid Presentation by TNF-Matured Dendritic Cells for Protection from Autoimmunity.
C. Wiethe, M. Schiemann, D. Busch, L. Haeberle, M. Kopf, G. Schuler, and M. B. Lutz (2007)
J. Immunol.
178, 4908-4916
|Abstract »|Full Text »|PDF »
From the Cover: Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals.
A. O. Speak, M. Salio, D. C. A. Neville, J. Fontaine, D. A. Priestman, N. Platt, T. Heare, T. D. Butters, R. A. Dwek, F. Trottein, et al. (2007)
PNAS
104, 5971-5976
|Abstract »|Full Text »|PDF »
From the Cover: Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency.
S. Porubsky, A. O. Speak, B. Luckow, V. Cerundolo, F. M. Platt, and H.-J. Grone (2007)
PNAS
104, 5977-5982
|Abstract »|Full Text »|PDF »
Natural killer T cells: Know thyself.
M. Kronenberg and L. Gapin (2007)
PNAS
104, 5713-5714
|Full Text »|PDF »
Mouse TCR{alpha}beta+CD8{alpha}{alpha} Intraepithelial Lymphocytes Express Genes That Down-Regulate Their Antigen Reactivity and Suppress Immune Responses.
T. L. Denning, S. Granger, D. Mucida, R. Graddy, G. Leclercq, W. Zhang, K. Honey, J. P. Rasmussen, H. Cheroutre, A. Y. Rudensky, et al. (2007)
J. Immunol.
178, 4230-4239
|Abstract »|Full Text »|PDF »
NKT cells: manipulable managers of joint inflammation.
K. Coppieters, P. Dewint, K. Van Beneden, P. Jacques, S. Seeuws, G. Verbruggen, D. Deforce, and D. Elewaut (2007)
Rheumatology
46, 565-571
|Abstract »|Full Text »|PDF »
Saposin B is the dominant saposin that facilitates lipid binding to human CD1d molecules.
W. Yuan, X. Qi, P. Tsang, S.-J. Kang, P. A. Illarionov, G. S. Besra, J. Gumperz, and P. Cresswell (2007)
PNAS
104, 5551-5556
|Abstract »|Full Text »|PDF »
MTP regulated by an alternate promoter is essential for NKT cell development.
S. K. Dougan, P. Rava, M. M. Hussain, and R. S. Blumberg (2007)
J. Exp. Med.
204, 533-545
|Abstract »|Full Text »|PDF »
Invariant NKT cells sustain specific B cell responses and memory.
G. Galli, P. Pittoni, E. Tonti, C. Malzone, Y. Uematsu, M. Tortoli, D. Maione, G. Volpini, O. Finco, S. Nuti, et al. (2007)
PNAS
104, 3984-3989
|Abstract »|Full Text »|PDF »
Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus.
J. Kis, P. Engelmann, K. Farkas, G. Richman, S. Eck, J. Lolley, H. Jalahej, M. Borowiec, S. C. Kent, A. Treszl, et al. (2007)
J. Leukoc. Biol.
81, 654-662
|Abstract »|Full Text »|PDF »
Invariant NKT Cells Amplify the Innate Immune Response to Lipopolysaccharide.
Dendritic Cell Function Can Be Modulated through Cooperative Actions of TLR Ligands and Invariant NKT Cells.
I. F. Hermans, J. D. Silk, U. Gileadi, S. H. Masri, D. Shepherd, K. J. Farrand, M. Salio, and V. Cerundolo (2007)
J. Immunol.
178, 2721-2729
|Abstract »|Full Text »|PDF »
Efficient Activation of V{alpha}14 Invariant NKT Cells by Foreign Lipid Antigen Is Associated with Concurrent Dendritic Cell-Specific Self Recognition.
L. Cheng, A. Ueno, S. Cho, J. S. Im, S. Golby, S. Hou, S. A. Porcelli, and Y. Yang (2007)
J. Immunol.
178, 2755-2762
|Abstract »|Full Text »|PDF »
Tumor Cells Loaded with {alpha}-Galactosylceramide Induce Innate NKT and NK Cell-Dependent Resistance to Tumor Implantation in Mice.
K. Shimizu, A. Goto, M. Fukui, M. Taniguchi, and S.-i. Fujii (2007)
J. Immunol.
178, 2853-2861
|Abstract »|Full Text »|PDF »
Prevention of Type 1 Diabetes by Invariant NKT Cells Is Independent of Peripheral CD1d Expression.
J. Novak, L. Beaudoin, S. Park, T. Griseri, L. Teyton, A. Bendelac, and A. Lehuen (2007)
J. Immunol.
178, 1332-1340
|Abstract »|Full Text »|PDF »
{beta}-Glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders.
E Zigmond, S Preston, O Pappo, G Lalazar, M Margalit, Z Shalev, L Zolotarov, D Friedman, R Alper, and Y Ilan (2007)
Gut
56, 82-89
|Abstract »|Full Text »|PDF »
Sensitivity of NK1.1-Negative NKT Cells to Transgenic BATF Defines a Role for Activator Protein-1 in the Expansion and Maturation of Immature NKT Cells in the Thymus.
A. J. Zullo, K. Benlagha, A. Bendelac, and E. J. Taparowsky (2007)
J. Immunol.
178, 58-66
|Abstract »|Full Text »|PDF »
C. M. Lappas, Y.-J. Day, M. A. Marshall, V. H. Engelhard, and J. Linden (2006)
J. Exp. Med.
203, 2639-2648
|Abstract »|Full Text »|PDF »
CD1 Antigen Presentation by Human Dendritic Cells as a Target for Herpes Simplex Virus Immune Evasion.
M. J. Raftery, F. Winau, S. H. E. Kaufmann, U. E. Schaible, and G. Schonrich (2006)
J. Immunol.
177, 6207-6214
|Abstract »|Full Text »|PDF »
Expression of CD1d Molecules by Human Schwann Cells and Potential Interactions with Immunoregulatory Invariant NK T Cells.
J. S. Im, N. Tapinos, G.-T. Chae, P. A. Illarionov, G. S. Besra, G. H. DeVries, R. L. Modlin, P. A. Sieling, A. Rambukkana, and S. A. Porcelli (2006)
J. Immunol.
177, 5226-5235
|Abstract »|Full Text »|PDF »
Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases.
S. D. Gadola, J. D. Silk, A. Jeans, P. A. Illarionov, M. Salio, G. S. Besra, R. Dwek, T. D. Butters, F. M. Platt, and V. Cerundolo (2006)
J. Exp. Med.
203, 2293-2303
|Abstract »|Full Text »|PDF »
Chewing the fat on natural killer T cell development.
D. I. Godfrey, M. J. McConville, and D. G. Pellicci (2006)
J. Exp. Med.
203, 2229-2232
|Abstract »|Full Text »|PDF »
Invariant NKT Cells Rapidly Activated via Immunization with Diverse Contact Antigens Collaborate In Vitro with B-1 Cells to Initiate Contact Sensitivity.
R. A. Campos, M. Szczepanik, M. Lisbonne, A. Itakura, M. Leite-de-Moraes, and P. W. Askenase (2006)
J. Immunol.
177, 3686-3694
|Abstract »|Full Text »|PDF »
Evaluation of the Function of Human Invariant NKT Cells from Cancer Patients Using {alpha}-Galactosylceramide-Loaded Murine Dendritic Cells..
K. Shimizu, M. Hidaka, N. Kadowaki, N. Makita, N. Konishi, K. Fujimoto, T. Uchiyama, F. Kawano, M. Taniguchi, and S.-i. Fujii (2006)
J. Immunol.
177, 3484-3492
|Abstract »|Full Text »|PDF »
Improving Antitumor Immune Responses by Circumventing Immunoregulatory Cells and Mechanisms..
G. Lizee, L. G. Radvanyi, W. W. Overwijk, and P. Hwu (2006)
Clin. Cancer Res.
12, 4794-4803
|Abstract »|Full Text »|PDF »
Glycolipid {alpha}-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice.
S.-i. Fujii, K. Shimizu, H. Hemmi, M. Fukui, A. J. Bonito, G. Chen, R. W. Franck, M. Tsuji, and R. M. Steinman (2006)
PNAS
103, 11252-11257
|Abstract »|Full Text »|PDF »
Effective gene therapy in an authentic model of Tay-Sachs-related diseases.
M. B. Cachon-Gonzalez, S. Z. Wang, A. Lynch, R. Ziegler, S. H. Cheng, and T. M. Cox (2006)
PNAS
103, 10373-10378
|Abstract »|Full Text »|PDF »
CD1d-Restricted T Cells License B Cells to Generate Long-Lasting Cytotoxic Antitumor Immunity In vivo..
Y. Chung, B.-S. Kim, Y.-J. Kim, H.-J. Ko, S.-Y. Ko, D.-H. Kim, and C.-Y. Kang (2006)
Cancer Res.
66, 6843-6850
|Abstract »|Full Text »|PDF »
Cutting Edge: Impaired Glycosphingolipid Trafficking and NKT Cell Development in Mice Lacking Niemann-Pick Type C1 Protein.
Y. Sagiv, K. Hudspeth, J. Mattner, N. Schrantz, R. K. Stern, D. Zhou, P. B. Savage, L. Teyton, and A. Bendelac (2006)
J. Immunol.
177, 26-30
|Abstract »|Full Text »|PDF »
T-cell recognition of glycolipids presented by CD1 proteins.
The Complementarity Determining Region 2 of BV8S2 (Vbeta8.2) Contributes to Antigen Recognition by Rat Invariant NKT Cell TCR..
E. Pyz, O. Naidenko, S. Miyake, T. Yamamura, I. Berberich, S. Cardell, M. Kronenberg, and T. Herrmann (2006)
J. Immunol.
176, 7447-7455
|Abstract »|Full Text »|PDF »
A unique lymphotoxin {alpha}beta-dependent pathway regulates thymic emigration of V{alpha}14 invariant natural killer T cells.
A. S. Franki, K. Van Beneden, P. Dewint, K. J. L. Hammond, S. Lambrecht, G. Leclercq, M. Kronenberg, D. Deforce, and D. Elewaut (2006)
PNAS
103, 9160-9165
|Abstract »|Full Text »|PDF »
Mechanisms imposing the V{beta} bias of V{alpha}14 natural killer T cells and consequences for microbial glycolipid recognition.
D. G. Wei, S. A. Curran, P. B. Savage, L. Teyton, and A. Bendelac (2006)
J. Exp. Med.
203, 1197-1207
|Abstract »|Full Text »|PDF »
Immature Human Dendritic Cells Infected with Leishmania infantum Are Resistant to NK-Mediated Cytolysis but Are Efficiently Recognized by NKT Cells.
Y. Campos-Martin, M. Colmenares, B. Gozalbo-Lopez, M. Lopez-Nunez, P. B. Savage, and E. Martinez-Naves (2006)
J. Immunol.
176, 6172-6179
|Abstract »|Full Text »|PDF »
Oral nickel tolerance: fas ligand-expressing invariant NK T cells promote tolerance induction by eliciting apoptotic death of antigen-carrying, effete B cells..
M. Nowak, F. Kopp, K. Roelofs-Haarhuis, X. Wu, and E. Gleichmann (2006)
J. Immunol.
176, 4581-4589
|Abstract »|Full Text »|PDF »
DOCK2 Is Required in T Cell Precursors for Development of V{alpha}14 NK T Cells..
Y. Kunisaki, Y. Tanaka, T. Sanui, A. Inayoshi, M. Noda, T. Nakayama, M. Harada, M. Taniguchi, T. Sasazuki, and Y. Fukui (2006)
J. Immunol.
176, 4640-4645
|Abstract »|Full Text »|PDF »